Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Juvenile Dermatomyositis Clinical Trials
Juvenile Dermatomyositis clinical trials are recruiting across 1 cities. Here are the cities with the most active studies:
About Juvenile Dermatomyositis
Juvenile dermatomyositis is a rare autoimmune disease in children causing muscle weakness and a distinctive skin rash. It is the most common inflammatory myopathy of childhood. Treatment includes corticosteroids, immunosuppressive medications, and physical therapy.
Clinical trials are advancing new treatments for juvenile dermatomyositis. Currently, 1 studies are recruiting a combined 5,000 participants across the United States. Research is being conducted by 1 organizations including National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
2026 Juvenile Dermatomyositis Research Landscape
As of July 2026, the juvenile dermatomyositis clinical trial landscape includes 1 actively recruiting studies across 1 cities in the United States. These studies are collectively seeking 5,000 participants, with an average enrollment target of 5,000 per study.
Research is being led by 1 organization, including National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
Geographically, juvenile dermatomyositis trials are most concentrated in Bethesda, Maryland (1 trial).
Featured Juvenile Dermatomyositis Studies
Highlighted recruiting studies for juvenile dermatomyositis, selected by enrollment size and research scope.
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
Purpose: The purpose of this protocol is 1. To comprehensively evaluate patients with autoinflammatory diseases clinically, genetically and immunologically at the autoinflammatory disease clinic at the NIH. 2. To follow patients with autoinflammatory Diseases that are genetically defined including Neonatal-Onset Multisystem Inflammatory Disease (NOMID), the most severe clinical phenotype of Cryop...
Frequently Asked Questions About Juvenile Dermatomyositis Clinical Trials
Are there juvenile dermatomyositis clinical trials near me?
Yes, there are 1 juvenile dermatomyositis clinical trials currently recruiting across 1+ cities in the United States, including Bethesda, Maryland. Browse the studies above to find one at a location convenient for you.
How do I join a juvenile dermatomyositis clinical trial?
To join a juvenile dermatomyositis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are juvenile dermatomyositis clinical trials free?
Yes, participation in juvenile dermatomyositis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of juvenile dermatomyositis treatments are being studied?
Current juvenile dermatomyositis clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in juvenile dermatomyositis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov